Wigs for Cancer Patients

Chemotherapy and radiation therapy for lymphoma can cause hair loss (called alopecia by doctors). For many people this is a scary thought; losing one's hair emphasizes feelings of fragility and signals to others that you have cancer. The use of wigs and hairpieces can help cancer patients cope with hair loss and preserve a feeling of dignity and respect.

You may also consider head scarves, a fashionable, comfortable option for those who are uncomfortable with wigs. See this page for more about head scarves

Though they are often stigmatized, a properly worn wig or hairpiece can be a very natural looking way to deal with losing one's hair during chemotherapy. However, a comfortable, natural-looking wig can be difficult to find.

When you are shopping for wigs or hairpieces, make sure to choose a vendor who will take the time to walk you through all of your options. Important considerations include:

Fabrication
100% human hair wigs are often touted as the best, but synthetic fibers are better for some customers.
Hair Length
A knowledgeable salesperson should be sensitive to whether you want to keep your current style or try something new.
Sizing
A wig that is the wrong size is going to look bad regardless of quality. Most wigs are adjustable but correct measurements will ensure the best fit.
Wig Construction
Most first-time customers need a crash course in wig construction. Options include capless, monofilament, and hand-tied.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap